Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSB | P07858 | 1/20 | 0.75 |
| ▸ | PPP3CB | P16298 | 1/20 | 0.75 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.66 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.66 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.41 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.41 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10220993 | 1.00 | CTSB (0.75) | CTSBPPP3CBABCC1ABCC2ABCG2 | |
| SCHEMBL13662172 | 1.00 | CTSB (0.75) | CTSBPPP3CBABCC1ABCC2ABCG2 | |
| SCHEMBL10220311 | 1.00 | CTSB (0.75) | CTSBPPP3CBABCC1ABCC2ABCG2 | |
| SCHEMBL14731781 | 1.00 | CTSB (0.75) | CTSBPPP3CBABCC1ABCC2ABCG2 | |
| SCHEMBL11952228 | 1.00 | CTSB (0.75) | CTSBPPP3CBABCC1ABCC2ABCG2 | |
| SCHEMBL11952943 | 1.00 | CTSB (0.75) | CTSBPPP3CBABCC1ABCC2ABCG2 | |
| SCHEMBL10220981 | 1.00 | CTSB (0.75) | CTSBPPP3CBABCC1ABCC2ABCG2 | |
| SCHEMBL14864651 | 1.00 | CTSB (0.75) | CTSBPPP3CBABCC1ABCC2ABCG2 | |
| SCHEMBL10220301 | 1.00 | CTSB (0.75) | CTSBPPP3CBABCC1ABCC2ABCG2 | |
| SCHEMBL8136974 | 1.00 | CTSB (0.75) | CTSBPPP3CBABCC1ABCC2ABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009005676-A2 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2009-01-08 | — | — | WO | disclosed |